000 | 01730 a2200457 4500 | ||
---|---|---|---|
005 | 20250513115008.0 | ||
264 | 0 | _c19970424 | |
008 | 199704s 0 0 eng d | ||
022 | _a0304-3959 | ||
024 | 7 |
_a10.1016/s0304-3959(96)03185-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBilsky, E J | |
245 | 0 | 0 |
_aCompetitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. _h[electronic resource] |
260 |
_bPain _cDec 1996 |
||
300 |
_a229-37 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAnalgesics, Opioid _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aDizocilpine Maleate _xtherapeutic use |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 | _aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- |
650 | 0 | 4 |
_aEnkephalins _xtherapeutic use |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aFentanyl _xtherapeutic use |
650 | 0 | 4 |
_aIsoquinolines _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 |
_aMorphine _xtherapeutic use |
650 | 0 | 4 |
_aOligopeptides _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Opioid, delta _xagonists |
650 | 0 | 4 |
_aReceptors, Opioid, mu _xagonists |
700 | 1 | _aInturrisi, C E | |
700 | 1 | _aSadée, W | |
700 | 1 | _aHruby, V J | |
700 | 1 | _aPorreca, F | |
773 | 0 |
_tPain _gvol. 68 _gno. 2-3 _gp. 229-37 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0304-3959(96)03185-5 _zAvailable from publisher's website |
999 |
_c9103335 _d9103335 |